• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伊波加因:复杂的药代动力学、安全性问题及初步疗效评估

Ibogaine: complex pharmacokinetics, concerns for safety, and preliminary efficacy measures.

作者信息

Mash D C, Kovera C A, Pablo J, Tyndale R F, Ervin F D, Williams I C, Singleton E G, Mayor M

机构信息

Department of Neurology, University of Miami School of Medicine, Florida 33136, USA.

出版信息

Ann N Y Acad Sci. 2000 Sep;914:394-401. doi: 10.1111/j.1749-6632.2000.tb05213.x.

DOI:10.1111/j.1749-6632.2000.tb05213.x
PMID:11085338
Abstract

Ibogaine is an indole alkaloid found in the roots of Tabernanthe Iboga (Apocynaceae family), a rain forest shrub that is native to western Africa. Ibogaine is used by indigenous peoples in low doses to combat fatigue, hunger and thirst, and in higher doses as a sacrament in religious rituals. Members of American and European addict self-help groups have claimed that ibogaine promotes long-term drug abstinence from addictive substances, including psychostimulants and opiates. Anecdotal reports attest that a single dose of ibogaine eliminates opiate withdrawal symptoms and reduces drug craving for extended periods of time. The purported efficacy of ibogaine for the treatment of drug dependence may be due in part to an active metabolite. The majority of ibogaine biotransformation proceeds via CYP2D6, including the O-demethylation of ibogaine to 12-hydroxyibogamine (noribogaine). Blood concentration-time effect profiles of ibogaine and noribogaine obtained for individual subjects after single oral dose administrations demonstrate complex pharmacokinetic profiles. Ibogaine has shown preliminary efficacy for opiate detoxification and for short-term stabilization of drug-dependent persons as they prepare to enter substance abuse treatment. We report here that ibogaine significantly decreased craving for cocaine and heroin during inpatient detoxification. Self-reports of depressive symptoms were also significantly lower after ibogaine treatment and at 30 days after program discharge. Because ibogaine is cleared rapidly from the blood, the beneficial aftereffects of the drug on craving and depressed mood may be related to the effects of noribogaine on the central nervous system.

摘要

伊博格碱是一种吲哚生物碱,存在于原产于西非的热带雨林灌木——伊博格(夹竹桃科)的根部。伊博格碱在低剂量时被当地居民用于对抗疲劳、饥饿和口渴,而在高剂量时则作为宗教仪式中的圣礼使用。美国和欧洲成瘾者自助组织的成员声称,伊博格碱能促进对包括精神兴奋剂和阿片类药物在内的成瘾物质的长期戒毒。轶事报告证明,单剂量的伊博格碱可消除阿片类药物戒断症状,并在较长时间内减少对药物的渴望。伊博格碱治疗药物依赖的所谓疗效可能部分归因于一种活性代谢物。伊博格碱的大多数生物转化是通过CYP2D6进行的,包括伊博格碱的O-去甲基化生成12-羟基伊博格胺(去甲伊博格碱)。个体受试者单次口服给药后获得的伊博格碱和去甲伊博格碱的血药浓度-时间效应曲线显示出复杂的药代动力学特征。伊博格碱已显示出在阿片类药物解毒以及药物依赖者准备进入药物滥用治疗时的短期稳定方面具有初步疗效。我们在此报告,伊博格碱在住院戒毒期间显著降低了对可卡因和海洛因的渴望。伊博格碱治疗后以及项目出院后30天,抑郁症状的自我报告也显著降低。由于伊博格碱从血液中清除迅速,该药物对渴望和抑郁情绪的有益后效应可能与去甲伊博格碱对中枢神经系统的作用有关。

相似文献

1
Ibogaine: complex pharmacokinetics, concerns for safety, and preliminary efficacy measures.伊波加因:复杂的药代动力学、安全性问题及初步疗效评估
Ann N Y Acad Sci. 2000 Sep;914:394-401. doi: 10.1111/j.1749-6632.2000.tb05213.x.
2
Medication development of ibogaine as a pharmacotherapy for drug dependence.作为药物依赖药物疗法的伊博格碱的药物研发。
Ann N Y Acad Sci. 1998 May 30;844:274-92.
3
Medication Development of Ibogaine as a Pharmacotherapy for Drug Dependence.伊博格碱作为药物依赖药物治疗的药物研发
Ann N Y Acad Sci. 1998 May;844(1):274-292. doi: 10.1111/j.1749-6632.1998.tb08242.x.
4
Influence of CYP2D6 activity on the pharmacokinetics and pharmacodynamics of a single 20 mg dose of ibogaine in healthy volunteers.CYP2D6活性对健康志愿者单次服用20毫克伊博格碱的药代动力学和药效学的影响。
J Clin Pharmacol. 2015 Jun;55(6):680-7. doi: 10.1002/jcph.471. Epub 2015 Feb 25.
5
Development of novel medications for drug addiction. The legacy of an African shrub.用于药物成瘾的新型药物的研发。一种非洲灌木的传承。
Ann N Y Acad Sci. 2000;909:88-103. doi: 10.1111/j.1749-6632.2000.tb06677.x.
6
How toxic is ibogaine?伊博格碱的毒性有多大?
Clin Toxicol (Phila). 2016;54(4):297-302. doi: 10.3109/15563650.2016.1138226. Epub 2016 Jan 25.
7
[Ibogaine - structure, influence on human body, clinical relevance].[伊博格碱——结构、对人体的影响、临床意义]
Pol Merkur Lekarski. 2016 Jul 29;41(241):50-55.
8
[Ibogaine--the substance for treatment of toxicomania. Neurochemical and pharmacological action].[伊波加因——治疗药物成瘾的物质。神经化学和药理作用]
Medicina (Kaunas). 2004;40(3):216-9.
9
Ibogaine Detoxification Transitions Opioid and Cocaine Abusers Between Dependence and Abstinence: Clinical Observations and Treatment Outcomes.伊波加因戒毒使阿片类药物和可卡因滥用者在依赖与戒断之间实现转变:临床观察与治疗结果
Front Pharmacol. 2018 Jun 5;9:529. doi: 10.3389/fphar.2018.00529. eCollection 2018.
10
IUPHAR - invited review - Ibogaine - A legacy within the current renaissance of psychedelic therapy.国际药理学联合会(IUPHAR)特邀综述——伊博格碱——当前迷幻疗法复兴中的一个遗产。
Pharmacol Res. 2023 Apr;190:106620. doi: 10.1016/j.phrs.2022.106620. Epub 2023 Mar 11.

引用本文的文献

1
Exploring Gender-Themed Lysergic Acid Diethylamide Experiences: A Subreddit Analysis.探索以性别为主题的麦角酸二乙酰胺体验:Reddit论坛分析
Psychedelic Med (New Rochelle). 2025 May 26;3(2):81-92. doi: 10.1089/psymed.2024.0025. eCollection 2025 Jun.
2
Analysis and characteristics of coronaridine, an alkaloid found in .从……中发现的一种生物碱——冠狗牙花定碱的分析与特性
Plant Biotechnol (Tokyo). 2024 Dec 25;41(4):387-392. doi: 10.5511/plantbiotechnology.24.0717a.
3
The Therapeutic Potential of Psychedelics in Treating Substance Use Disorders: A Review of Clinical Trials.
迷幻剂在治疗物质使用障碍中的治疗潜力:临床试验综述
Medicina (Kaunas). 2025 Feb 6;61(2):278. doi: 10.3390/medicina61020278.
4
Cardiovascular effects and safety of classic psychedelics.经典致幻剂的心血管效应与安全性
Nat Cardiovasc Res. 2025 Feb;4(2):131-144. doi: 10.1038/s44161-025-00608-2. Epub 2025 Feb 5.
5
Ibogaine administration following repeated morphine administration upregulates myelination markers 2', 3'-cyclic nucleotide 3'-phosphodiesterase (CNP) and myelin basic protein (MBP) mRNA and protein expression in the internal capsule of Sprague Dawley rats.在重复给予吗啡后给予伊波加因,可上调斯普拉格-道利大鼠内囊区髓鞘形成标志物2',3'-环核苷酸3'-磷酸二酯酶(CNP)和髓鞘碱性蛋白(MBP)的mRNA及蛋白表达。
Front Neurosci. 2024 Jul 24;18:1378841. doi: 10.3389/fnins.2024.1378841. eCollection 2024.
6
Current Perspectives on the Clinical Research and Medicalization of Psychedelic Drugs for Addiction Treatments: Safety, Efficacy, Limitations and Challenges.当前对迷幻药物治疗成瘾的临床研究和医学化的观点:安全性、疗效、局限性和挑战。
CNS Drugs. 2024 Oct;38(10):771-789. doi: 10.1007/s40263-024-01101-3. Epub 2024 Jul 20.
7
Ibogaine Induces Cardiotoxic Necrosis in Rats-The Role of Redox Processes.伊博加因诱导大鼠心脏毒性坏死——氧化还原过程的作用。
Int J Mol Sci. 2024 Jun 13;25(12):6527. doi: 10.3390/ijms25126527.
8
From taboo to treatment: The emergence of psychedelics in the management of pain and opioid use disorder.从禁忌到治疗:迷幻药在疼痛管理和阿片类药物使用障碍治疗中的兴起。
Br J Clin Pharmacol. 2024 Dec;90(12):3036-3053. doi: 10.1111/bcp.16045. Epub 2024 Apr 16.
9
The pharmacokinetics and pharmacodynamics of ibogaine in opioid use disorder patients.阿片类物质使用障碍患者伊博加因的药代动力学和药效学。
J Psychopharmacol. 2024 May;38(5):481-488. doi: 10.1177/02698811241237873. Epub 2024 Mar 22.
10
5-HT Receptor Knockout Mice Show Sex-Dependent Differences following Acute Noribogaine Administration.5-HT 受体敲除小鼠在急性去甲博莱霉素给药后表现出性别依赖性差异。
Int J Mol Sci. 2024 Jan 5;25(2):687. doi: 10.3390/ijms25020687.